Carmen Lazala
Pediatric Endocrinology · Bronx, NYNPI 1851350730
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,159 and has fallen 58.2% since, to $485 in 2025.
Across 224 payments — averaging $25.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Pfizer$717
- Novo Nordisk$622
- Biomarin Pharmaceutical Inc.$437
- Azurity Pharmaceuticals, Inc.$421
- Tolmar, Inc.$334
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,61099%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 36 | $1,067 |
| Pfizer | 18 | $717 |
| Novo Nordisk | 30 | $622 |
| Biomarin Pharmaceutical Inc. | 5 | $437 |
| Azurity Pharmaceuticals, Inc. | 21 | $421 |
| Tolmar, Inc. | 14 | $334 |
| AbbVie | 15 | $313 |
| Ascendis Pharma Endocrinology Inc | 11 | $250 |
| Tolmar Pharmaceuticals, Inc. | 13 | $222 |
| Endo USA, Inc. | 7 | $159 |
| Ipsen Biopharmaceuticals, Inc | 7 | $143 |
| Xeris Pharmaceuticals, Inc. | 6 | $137 |
| Merck | 5 | $113 |
| Cumberland Pharmaceuticals, Inc. | 6 | $107 |
| Phadia US Inc. | 4 | $67 |
| Lilly USA, LLC | 3 | $65 |
| AstraZeneca | 2 | $60 |
| Insulet Corporation | 3 | $52 |
| Sanofi Pasteur Inc. | 2 | $52 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Eton Pharmaceuticals, Inc. | 2 | $43 |
| Ultragenyx Pharmaceutical Inc. | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Dexcom, Inc. | 2 | $37 |
| Rhythm Pharmaceuticals, Inc. | 2 | $36 |
| Oxford Immunotec USA Inc | 1 | $27 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EUCRISA$250
- BEXSERO$244
- VOXZOGO 1.2mg$121
- TRUMENBA$110
How this compares
$5,645 in reported general payments places this provider in the 75th percentile of 138 pediatric endocrinology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 15 | $15,013 |
| JardianceEmpagliflozin | 13 | $9,748 |
| EliquisApixaban | 13 | $5,623 |
| Valsartan | 14 | $221 |
| Omeprazole | 13 | $81 |
| Atorvastatin Calcium | 13 | $67 |
| Spironolactone | 13 | $42 |
| Carvedilol | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $65 | $15,01315 claims |
| PfizerEliquis | $717 | $5,62313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in Bronx
- Angela VerardoBronx$38K
- Laurie CohenBronx$27K
- Despoina GaletakiBronx$4K
- Zoltan AntalBronx$2K
- Paul SaengerMineola$180K
- Alicia RomanoSleepy Hollow$157K
- Svetlana TenStaten Island$101K
- Robert RapaportNew York$98K
- Moris AnguloMineola$73K
- Jill BrodskyPoughkeepsie$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.